Recruiting

Who we are

  • December 22, 2023
    A Study of CNA3103 (LGR5-targeted, Autologous CAR-T Cells) Administered to Subjects With Metastatic Colorectal Cancer
  • December 22, 2023
    RC48-ADC Combined With Bevacizumab in HER2-positive Advanced Colorectal Cancer
  • November 13, 2023
    Phase 1 Dose Escalation and Expansion Study of TROP2 CAR Engineered IL15-transduced Cord Blood-derived NK Cells in Patients With Advanced Solid Tumors (TROPIKANA)
  • October 31, 2023
    Adjuvant Durvalumab Plus Regorafenib vs Untreated Control in Stage IV Colorectal Cancer Patients With no Evidence of Disease (NED): VIVA Trial
  • October 31, 2023
    Comparing Chidamide+Sintilimab+Bev With Standard Second-line FOLFIRI+Bev in Advanced MSS/pMMR mCRC
  • October 17, 2023
    Envafolimab Combined With Trifluridine/Tipiracil and Bevacizumab in the Treatment of Refractory mCRC.
  • October 17, 2023
    Sacituzumab Govitecan in Combination With Capecitabine for Advanced Gastrointestinal Cancers After Progression on Standard Therapy
  • April 12, 2023
    Evaluation for NCI Surgery Branch Immunotherapy Clinical Research Protocols
  • April 12, 2023
    Neo-T in Treating Patients With Advanced Solid Tumors(GI-NeoT-03)
  • December 8, 2022
    Evaluating Novel Therapies in ctDNA Positive GI Cancers